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GABA is a major inhibitory neurotransmitter in the mammalian central nervous system
(CNS). Inhibitory GABAA channel circuits in the dorsal spinal cord are the gatekeepers of
the nociceptive input from the periphery to the CNS. Weakening of these spinal inhibitory
mechanisms is a hallmark of chronic pain. Yet, recent studies have suggested the
existence of an earlier GABAergic “gate” within the peripheral sensory ganglia. In this
study, we performed systematic investigation of plastic changes of the GABA-related
proteins in the dorsal root ganglion (DRG) in the process of neuropathic pain development.
We found that chronic constriction injury (CCI) induced general downregulation of most
GABAA channel subunits and the GABA-producing enzyme, glutamate decarboxylase,
consistent with the weakening of the GABAergic inhibition at the periphery. Strikingly, the
α5 GABAA subunit was consistently upregulated. Knock-down of the α5 subunit in vivo
moderately alleviated neuropathic hyperalgesia. Our findings suggest that while the
development of neuropathic pain is generally accompanied by weakening of the
peripheral GABAergic system, the α5 GABAA subunit may have a unique pro-algesic
role and, hence, might represent a new therapeutic target.
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INTRODUCTION
The inhibitory GABAergic and glycinergic interneurons are crucial components of the “gate” on the
way of nociceptive input to the spinal cord, proposed over 50 years ago in the gate control theory of
pain (Melzack and Wall, 1965). These interneurons conduct pre- or postsynaptic inhibition with
regard to excitatory interneurons, projection neurons, and primary afferent terminals and, thus,
control the transmission of nociceptive information from the periphery (Braz et al., 2014; Duan et al.,
2014; Mendell, 2014; Peirs et al., 2015; Zhang et al., 2018).
GABA is an important inhibitory neurotransmitter in the mammalian central nervous system
(CNS). Its inhibitory effects are mediated via anion-selective ionotropic GABAA receptors and
metabotropic GABAB receptors (Kumar et al., 2013; Ito, 2016). The activation of GABAA receptors in
most adult CNS neurons leads to an influx of Cl−, resulting in membrane hyperpolarization and
suppression of neuronal excitability. In contrast to the central nervous system, GABAA receptor
activation in the primary sensory neurons causes primary afferent depolarization (PAD) (Price et al.,
2009; Wilke et al., 2020). GABAA-mediated depolarization occurs due to the accumulation of high
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Cl−-importing transporter, NKCC1, relative to the expression of
the Cl−-extruding transporter, KCC2 (Coull et al., 2003; Pitcher
and Cervero, 2010). PAD inhibits peripheral input to the spinal
cord, mainly due to the shunting effect of GABAA Cl
−
conductance, resulting in a reduction in the incoming spike
amplitude and presynaptic Ca2+ influx, and subsequently
reduced neurotransmitter release from presynaptic terminals
of peripheral afferents (Watson et al., 2005). However, in
certain pathological situations, due to the increase in NKCC1
activity and further [Cl−]i accumulation, the GABA-induced
depolarization may drive the membrane potential toward the
action potential threshold, resulting in a dorsal root reflex (DRR)
(Willis, 1999; Price et al., 2009).
Although it is generally accepted that the spinal dorsal horn is the
first point of integration of pain signals within the somatosensory
pathways, growing evidence has suggested that primary sensory
neurons can also influence sensory transmission in the manner of
an additional “gate” or “filter” (Dun, 1955; Stoney, 1990; Gemes et al.,
2013; Du et al., 2014; Du et al., 2017). Thus, we recently demonstrated
that dorsal root ganglion (DRG) neurons expressed proteins
necessary for GABA synthesis, transport, and release, as well as
multiple GABA receptor subunits (Du et al., 2017). DRG neurons are
pseudounipolar, that is, they emit single axons that bifurcate into
central and peripheral branches; somatic GABAA receptor activation
in DRG neurons inhibits nociceptive transmission through the
ganglion mainly by increasing the rate of spike failure to
propagate through the axonal bifurcation (t-junction).
Pharmacological, chemogenetic, or optogenetic stimulation of the
GABAergic system within the DRG in vivo strongly alleviated
physiological (nociceptive), inflammatory, and neuropathic pain
(Du et al., 2017).
Reduction or elimination of spinal cord inhibitory circuits is
reported to play a role in generating chronic pain states
(Sugimoto et al., 1990; Moore et al., 2002; Lever et al., 2003;
Scholz et al., 2005; Etlin et al., 2016; Llewellyn-Smith et al., 2018).
For instance, downregulation of the GABA-synthesizing enzyme
(Moore et al., 2002), pre- and postsynaptic GABA receptors
(Polgar and Todd, 2008), or dysregulation of Cl− homeostasis
(Chen et al., 2014; Modol et al., 2014) in the spinal dorsal horn
are important contributors to the generating of neuropathic pain.
Moreover, restoration of the spinal GABAergic inhibitory system by
implantation of GABAergic progenitor cells provides long-lasting
pain relief (Etlin et al., 2016; Llewellyn-Smith et al., 2018). Although
there are some relevant reports, our understanding of chronic
pain–associated plasticity within the peripheral GABAergic system
is still incomplete (Pathirathna et al., 2005; Price et al., 2009; Zhu et al.,
2012; Zhang et al., 2015; Loeza-Alcocer et al., 2019). Therefore, in this
study, we aimed to examine the changes in the functional expression
of GABA-related proteins in DRG neurons during the development
of neuropathic pain induced by chronic constriction injury (CCI) of
the sciatic nerve.
MATERIALS AND METHODS
Animals. Adult male Sprague Dawley rats (180–200 g) were used
in this study. All animal experiments were approved by the
Animal Care and Ethical Committee of Hebei Medical
University (Shijiazhuang, China) and were in accordance with
the International Association for the Study of Pain guidelines for
animal use. The ethical approval reference number is IACUC-
Hebmu-2020007.
Neuronal cultures. DRG neurons were dissociated and
cultured as described previously (Linley et al., 2008; Liu et al.,
2010). Briefly, adult rats were humanely euthanized by cervical
dislocation under isoflurane anesthesia. Rats were decapitated,
and the spines were removed and sectioned longitudinally. L4-6
DRGs were removed and dissociated, respectively, in Hank’s
Balanced Salt Solution supplemented with 1 mg/ml type 1A
collagenase (Sigma-Aldrich) and 10 mg/ml dispase (Invitrogen)
in a humidified incubator at 37°C and 5% CO2 for 30 min.
Ganglia were then gently triturated, washed twice by
centrifugation, and resuspended in 600 μl culturing medium;
this suspension was then plated onto 10-mm glass coverslips
pre-coated with poly-D-lysine and laminin. Neurons were left to
attach to the coverslips for 4–8 h in a humidified incubator (37°C,
5% CO2) and were recorded straight after.
Electrophysiology. Gramicidin-perforated patch clamp
recordings were used to record GABA currents from DRG
neurons at room temperature. Patch pipettes (with a
resistance of 2–4 MΩ) were fabricated from borosilicate
glass capillaries using a Sutter P-97 puller (Sutter) and fire-
polished. Currents were amplified and recorded using an
Axon MultiClamp 700B amplifier and pClamp 10.4
software (Axon Instruments) and were sampled at a
frequency of 5 kHz. GABA currents from DRG neurons
were recorded at a holding potential of −60 mV. The bath
solution contained the following (in mM): NaCl (145), KCl
(5), CaCl2 (2), MgCl2 (2), HEPES (10), and glucose (10), with a
pH value of 7.4, adjusted with NaOH. The pipette solution
contained (in mM): KCl (150), MgCl2 (5), HEPES (10), Mg-
ATP (3), and Na-GTP (0.6), supplemented with 400 μg/m
gramicidin (Sigma), with a pH value of 7.4, adjusted
with KOH.
Quantitative real-time RT-PCR. Total RNA from the
combined L4–L6 DRGs of an adult rat with CCI or a sham-
operated control rat was extracted using a commercial RNA
isolation kit at 5 or 14 days after operation (RNAiso, Takara).
Isolated RNA was dissolved in 20 μl diethyl
pyrocarbonate–treated (DEPC-treated) water and reverse-
transcribed using a PrimeScriptRT™ reagent kit (Takara) and
a thermal cycler (Mastercycler, Eppendorf). Quantitative PCR
reaction was performed using SYBR Premix Ex TaqII (Takara),
and the fluorescent DNA was detected and quantified using an
FQD-48A (A4) system (BIOER). A list of primers used in
standard RT-PCR experiments is given in Supplementary
Table S1.
Western blotting. The DRG lysates were prepared with RIPA
lysis buffer and protein quantified using a BCA Protein Assay Kit
(Thermo). About 20 µg of protein was dissolved in 5 × SDS
sample buffer (Invitrogen) and separated on NuPAGE 8%
Bis–Tris gels (Invitrogen) for 120 min at 80 mV. Protein bands
were then electro-transferred to a polyvinylidene difluoride
membrane (Thermo Scientific) for 150 min at 200 mA.
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Membranes were blocked with 5% nonfat milk/TBST for 1.5 h at
room temperature and incubated with the primary antibody
against the α5 GABAA subunit (Abcam) and GAPDH
(Proteintech) in 5% nonfat milk/TBST overnight at 4°C. The
blots were visualized by enhanced chemiluminescence, and
images were captured by using a Kodak Image Station 4000 R
and quantified using Kodak MI SE software. GAPDH was used as
the internal control.
Immunocytochemistry. DRGs were excised, submerged in
Tissue-Tek O.C.T. (Sakura), frozen, and sectioned (8 μm)
using a freezing microtome CM 1950 (Leica). DRG slices
were fixed in 4% paraformaldehyde (PFA) for 15 min at
room temperature (RT). Cells were washed three times
with PBS and then permeabilized with 0.1% Triton X-100
for 10 min at RT. To block nonspecific antibody binding, cells
were incubated with 10% goat serum in PBS (blocking buffer)
for 30–60 min at RT. DRG slices were then incubated
overnight with antibodies against α1 (Abcam, cat. no.
ab252430, 1:100), α4 (Abcam, cat. no. ab242008, 1:100), α5
(Abcam, cat. no. ab259880, 1:200), and β2 (Abcam, cat. no.
ab15600, 1:100) of GABAA subunits, the GABAB2 (Santa, cat.
no. qy-1324R, 1:100) subunit, NF200 (Sigma, cat. no. N5389,
1:100), CGRP (Abcam, cat. no. ab81877, 1:100), IB4 (Sigma,
cat. no. 2176690, 1:100), GAT1 (Abcam, cat. no. ab277642, 1:
100), and IgG control (Abcam) in blocking buffer at 4°C. After
being washed three times with blocking buffer, cells were
stained with fluorophore-conjugated secondary antibodies
(Jackson) for 1 h at RT. As controls for specificity, the
primary antibodies were co-incubated with the
corresponding immunization peptides, or cells were
incubated with the secondary antibody only. All images
were collected using a Leica inverted confocal microscope
(Leica SP5).
Chronic pain models. All surgical procedures were
performed under deep anesthesia with an i.p. injection of
chloral hydrate (60–80 mg/kg) in accordance with the Animal
Care and Ethical Committee of Hebei Medical University and
under the International Association for the Study of Pain
guidelines. Chronic constriction injury (CCI) was performed
as described previously (Sommer and Schafers, 1998). Briefly,
rats were anesthetized with an i.p. injection of sodium chloral
hydrate (60–80 mg/kg). The right hind leg was shaved and
cleaned using 70% ethanol. The sciatic nerve was exposed by
blunt dissection at the mid-thigh level, proximal to the sciatic
trifurcation. Four nonabsorbable sterile surgical sutures (4–0
chromic gut) were loosely tied around the sciatic nerve with
an approximately 1.0-to-1.5-mm interval between the knots.
In sham-operated animals, the sciatic nerve was exposed but
not manipulated. The skin was sutured, and the animal was
transferred to a recovery cage.
Behavioral tests. In behavioral tests, animals were habituated
to the testing environment for 3 h before behavioral testing.
Mechanical and thermal sensitivities were analyzed using the
von Frey and Hargreaves methods, respectively, by an operator
unaware of the details of the surgical procedure undertaken. The
mechanical withdrawal threshold was measured using a set of von
Frey filaments (Stoelting Co.) with a calibrated range of bending
force (2, 4, 6, 8, and 10 g). Each rat was placed into a plastic cage
with a wire mesh bottom. A single filament was applied
perpendicularly to the plantar surface of the hind paw five
times with an interval of 5 s. Positive response was defined as
at least three clear withdrawal responses out of five applications.
Filaments were applied in an up-and-down order according to a
negative or positive response to determine the hind paw
withdrawal threshold. Thermal withdrawal latency was tested
using a radiant heat lamp source (PL-200, Taimeng Co.). The
intensity of the heat source was maintained at 10 ± 0.1%. Rats
were placed individually into plexiglass cubicles placed on a
transparent glass surface. The light beam from the radiant
heat lamp, located below the glass, was directed at the plantar
surface of the hind paw. The time was recorded from the onset of
radiant heat stimulation to the withdrawal of the hind paw. Three
trials with an interval of 5 min were carried out for each rat, and
scores from the three trials were averaged.
Acute focal application of the AAV2/5 virus to DRG in vivo.
AAV2/5-CMV-alpha5 shRNA-GFP (shRNA coding sequence:
GCACACTTCTCTACACCATGC) and AAV2/5-CMV-GFP
viruses were produced by Hanbio Biotechnology Co., Ltd.
Virus injections into the L5 DRG were performed as described
(Du et al., 2017) under deep anesthesia with an i.p. injection of
chloral hydrate (60–80 mg/kg). Briefly, L5 DRGs were exposed by
the removal of both spinous and transverse processes of the
vertebral bone. A microinjector (Hamilton Co.) was inserted into
the ganglion to a depth of 500 μm from the exposed surface. The
virus solution (5 μl, ∼8×1012 vg/ml of Control shRNA or α5
shRNA) was injected using a constant flow pump at 2 μl/min,
and the needle was removed 3 min after the injection was
complete. The muscles overlying the spinal cord were loosely
sutured together, and the wound was closed. Animals were
allowed to recover for at least 4 weeks before the experiments
were carried out. Animals developing signs of distress were
humanely euthanized. After injection of the AAV2/5 virus into
the DRG, the mechanical and thermal sensitivity were analyzed
by an operator blind to the viral construct allocation; the von Frey
and Hargreaves tests were performed once a week. In some cases,
after the behavior testing, some rats were humanely euthanized,
and the DRG was extracted for GFP visualization or for
quantitative real-time RT-PCR to verify the infection
efficiency. In animals subjected to CCI or sham operations,
the behavior tests were performed on days 1, 3, 5, 7, 10, and 14.
Acute focal application of drugs to DRG in vivo. A DRG
cannula for focal application of substances to the DRG was
implanted as previously described (Du et al., 2017). Briefly, a
midline incision was made at the L4–L6 spinal level of adult male
rats (Sprague Dawley; 180–200 g), and the L5 was identified at the
midpoint of a link between both sides of the iliac crest. A 0.8-mm
hole (∼1 mm off the inferior edge of the transverse process) was
drilled through the transverse process over the L5 DRG. The
approaching of a ganglion was verified by the twitch of the paw. A
hooked stainless steel blunt-tip cannula (inner diameter 0.64 mm,
length 4 mm) was forced into the hole and connected to a
polypropylene tube (inner diameter 0.41 mm, length 4.5 mm).
The incision was closed with sutures, and the cannula was firmly
fixed in place with dental cement.
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FIGURE 1 | Expression of GABA-related proteins in DRG neurons. Immunofluorescent images of α1 (A), α4 (B), α5 (C), and β2 (D) of the GABAA receptor, B2
subunit of the GABAB receptor (E), and GAT1 (F) in rat DRG neurons. The co-localization of these proteins (red) and sensory neuron markers CGRP, IB4, and NF200
(green) were analyzed. Arrows indicate the representative neurons with co-localization of tested proteins and sensory neuronmarkers. Micrographs within each panel are
of the same magnification; scale bar represents 50 μm.
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For continuous local delivery of drugs, osmotic minipumps
(ALZET osmotic pump model 2002) were implanted s.c. in the
neck while the cannula tube (ALZET Brain infusion kit 2)
connected to the pump was inserted into the DRG as
described above. Before the implantation, the infusion
drain assembly with the attached osmotic pump was
incubated in sterile saline (0.9%) at 37°C for 6 h, after
which the minipumps were filled with saline (0.9%) or the
α5-GABAA receptor inhibitor, L655708(20 μM). This pump
model releases approximately 0.5 μl/h for 14 days. Chronic
pain surgical procedures were performed immediately.
Intramuscular injection of benzylpenicillin (19 mg/0.1 ml)
was given immediately after surgery. Postoperatively, rats
were housed individually in plastic cages with sawdust
flooring and supplied with water and food ad libitum.
Animals were left to recover for at least 24 h before the
experiments were carried out.
Statistics. All data are given asmean ± SEM. Differences between
the two groups were assessed using unpaired 2-tailed Student’s t-test.
Hyperalgesia data in chronic pain models were analyzed using
repeated measures ANOVA with the Bonferroni correction.
Multiple groups were compared using one-way ANOVA with the
Bonferroni correction. The Mann–Whitney test was used for data
that failed normality testing. Pearson’s chi-square test was used for
comparing the different proportions between the groups. Differences
were considered significant at p ≤ 0.05. Statistical analyses were
performed using OriginPro 9.1 and SPSS. The number of
experiments is indicated in each figure; single, double, and triple
symbols indicate significant difference from the appropriate control
with p ≤ 0.05, 0.01, or 0.001, respectively.
RESULTS
Expression of Gamma-Aminobutyric
Acid–Related Proteins in Dorsal Root
Ganglion Neurons of Rats.
Our previous study demonstrated that DRG neurons express
mRNAs of key proteins necessary for GABAergic
transmission, including multiple GABAA and GABAB
receptor subunits, the glutamate decarboxylase isoforms
GAD65 and GAD67 (enzymes that decarboxylate
glutamate to produce GABA), the vesicular GABA
transporter VGAT (which packs GABA into the release
vesicles), and the plasma membrane GABA transporters,
Gat1–3 (which remove released GABA from the
extracellular space). In the present study, we aimed to
evaluate possible changes in the DRG’s GABA system that
are induced by nerve injury; hence, as a first step, we
performed immunohistochemical analysis of expression
patterns for key GABAA and GABAB receptors and GAT1
in the rat DRG (Figure 1). The GABAA receptor subunits α1,
α4, α5, and β2 (Figures 1A–D) were strongly expressed in the
majority of DRG neurons; the expression patterns were
partially overlapping with markers of sensory neuron
subtypes as follows: CGRP (peptidergic nociceptors), IB4
(nonpeptidergic nociceptors), and NF200 (myelinated
fibers) (Figures 1A–D). Likewise, the B2 subunit of
GABAB receptors and GABA transporter GAT1 were
found abundantly expressed in these subtypes of DRG
neurons (Figures 1E,F). The size distributions of neurons
expressing each GABA-related protein are analyzed in
Figure 2. The size distributions of neurons expressing
each GABA-related protein and co-localization with DRG
neuron markers are reported in Figure 2. On average, each
protein tested was expressed in more than 50% of all DRG
neurons and was significantly present in each tested
subpopulation (i.e., CGRP+, IB4+, and NF200+; Figures
2A–F). α5, β2, and B2 subunits did not reveal a significant
bias toward neurons of a particular size or modality.
Interestingly, the α1 subunit was present in a significantly
lower proportion of CGRP+ neurons than in IB4+ neurons
and NF200+ neurons (p  0.000, p  0.005, respectively;
Figure 2A2), while the α4 subunit showed a tendency to
localize to neurons with a smaller diameter (Figure 2B1) and
was expressed in significantly higher proportions of CGRP+
and IB4+ neurons than in NF200+ neurons (p  0.0025, p 
0.001, respectively; Figure 2B2). The expression of GAT1 was
significantly higher in NF200+ neurons than in CGRP+ and
IB4+ neurons (p  0.03, p  0.031, respectively; Figure 2F2).
These results provided further evidence for the existence of
peripheral GABAergic signaling within dorsal root ganglia.
Neuropathic Injury Induces Plastic Changes
in Gamma-Aminobutyric Acid–ergic System
of Dorsal Root Ganglion Neurons
Next, we tested if neuropathic injury would induce any change
in the expression of GABAergic system components in the
DRG. We used chronic constriction injury (CCI) of the sciatic
nerve (Bennett and Xie, 1988) in these experiments. CCI
induced characteristic, long-lasting hypersensitivity to
mechanical and thermal stimuli (Figures 3A,B). RT-PCR
analysis of the mRNA of GABA-related genes in ipsilateral
L4–L6 DRGs is shown in Figures 3C,D. Consistent with the
previous report and with immunohistochemistry data
(Figure 1), transcripts for the α1–3 and 5, β1–3, and γ1–3
GABAA subunits, the B1 and B2 GABAB subunits, GAD67,
GAT1-3, and NKCC1 were all reliably detectable in the DRG.
Compared to the sham group, CCI induced significant
increase in the mRNA level of a neuronal injury marker,
activating transcription factor 3 (ATF3) (Xu and Yaksh,
2011) at both 5 (Figure 3C) and 14 (Figure 3D) days after
injury, confirming neuropathic remodeling of the peripheral
nerves. We then analyzed CCI-induced changes in GABA-
related genes. At the 5th day after injury, there were
bidirectional changes with α1, γ2, and GAD67 being
downregulated while α2, α5, β3, GAT2, and NKCC1
upregulated to various extents (Figure 3C). However, by
day 14, the general downregulation of GABA receptors and
GAD67 became apparent, with α1, α2, γ2, γ3, and GAD67 all
being found to be significantly downregulated and (with the
exception of α5, see below) all other genes being without a
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significant change. No obvious changes of GABAB receptors
were observed at either time point. Concurrent
downregulation of both GABAA subunits and GAD67
indicates the overall weakening of the inhibitory
GABAergic system in the DRG throughout neuropathic
pain development.
The one striking exception from the overall reduction in the
GABAA subunit transcript level was the α5 GABAA subunit, which
FIGURE 2 | Distributions of GABA-related proteins in DRG neurons. The somatic diameters of neurons positive for α1 (A1), α4 (B1), α5 (C1), and β2 (D1) of the
GABAA receptor, B2 subunit of the GABAB receptor (E1), and GAT1 (F1)were measured and plotted as size-distribution histograms. Percentages of CGRP-, IB4-, and
NF200-positive neurons in each GABA-related protein–positive DRG neuron were shown in (A2–F2), respectively. *p < 0.05, **p < 0.01, ***p < 0.001 (Pearson’s
chisquare test).
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was consistently and strongly upregulated both at day 5 and at day 14
(Figures 3C,D). The protein levels of α5 were also consistently
increased after CCI (as compared to the sham group; Figure 3E).
Gamma-Aminobutyric Acid–Cl- Currents
Evoked From Dorsal Root Ganglion
Neurons of Neuropathic Pain Rats
To investigate if changes in GABAA subunit expression affected
the amplitude of GABAA currents in DRG neurons from
neuropathic animals, we performed patch recording of the
GABAA current from the acutely dissociated DRG neurons
in response to 200 μM GABA from rats subjected to either
CCI or a sham procedure. Figure 4 presents the comparison of
GABA-induced currents from the DRG neurons of sham-
operated animals and animals 5 and 14 days after the CCI. In
analyzing these data, we separated the neurons into small
(whole-cell capacitance <30 pF, Figure 4A), medium (whole-
cell capacitance 30–80 pF, Figure 4B), and large neurons
(whole-cell capacitance >80 pF, Figure 4C), representing
mostly C, Aδ, and Aβ fibers, respectively (Rola et al., 2003).
There was a significant reduction in the GABAA current
amplitude in small-diameter DRG neurons 14 days after the
surgery, which is in good agreement with the RT-PCR data
(Figure 3D). There were no significant changes in the amplitude
of GABA responses in the other DRG groups; there was a
tendency toward larger responses at the 5th day after the
CCI in large neurons, and at day 14, the currents were
somewhat reduced in both medium and large neurons, but
these tendencies did not reach significance.
FIGURE 3 | Expression of GABA-related components in the DRG induced by neuropathic pain. (A,B) Mechanical threshold (A) and thermal latency (B) were
significantly reduced during the two weeks after CCI surgery in rats. Repeatedmeasures ANOVAwith the Bonferroni correction was used for comparison of hyperalgesia
measurements between the sham and CCI groups: #p < 0.05, ##p < 0.01; one-way ANOVA was used for comparison within the corresponding time point: *p < 0.05.
(C,D)mRNA relative expression level of indicated GABA-related components in the L4–6 DRGs of rats on the 5th (C) and 14th (D) days after CCI surgery compared
with the sham group. GAPDH was used as the internal reference for the mRNA expression level. One-way ANOVA with the Dunnett post hoc test was used for
comparison between the tested group and the sham group: *p < 0.05, **p < 0.01, ***p < 0.001. (E) Western blot analysis of the α5 subunit of the GABAA receptor
in the L4–6 DRGs of rats on the 5th and 14th days after CCI surgery (left, the representative results; right, summary of the changes in the α5 protein level). *p < 0.05,
**p < 0.01(unpaired t-test). Number of experiments is indicated as n in each panel.
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Interestingly, in the small and large neuron subpopulations, the
majority of neurons (over 80%) responded to GABA with sizable
inward currents (both in control and in CCI animals) (Figures
4A,C). In contrast, only ∼50% of medium neurons from the sham
controls responded to GABA (Figure 4B), but the proportion of
responding neurons was significantly higher after the CCI (∼94 and
∼93% at 5 and 14 days after the CCI, respectively; Figure 4B). One
hypothesis is that the increase in the proportion ofGABA-responding
medium neurons may be caused by CCI-induced overexpression of
the α5 GABAA subunit (Figures 3C–E).
In Vivo Silencing of the
α5 Gamma-Aminobutyric AcidA Subunit
Alleviates Neuropathic Pain
Our data thus far demonstrated upregulation of the α5 GABAA
subunit and a concurrent increase in the proportion of
GABA-responsive medium-size neurons during the
development of CCI-induced neuropathic pain. Thus, we
hypothesized that the α5 subunit may play a unique pro-
algesic role in the sensory nerves. We then set out to
investigate how an in vivo silencing of this GABAA subunit in
DRG neurons might affect the development of the neuropathic
pain. We used an shRNA knockdown approach whereby the
AAV2/5-shRNA-GFP virus against the α5 subunit was designed
and directly injected into the L5 DRG of rats (see Materials and
Methods). The control rats were injected with AAV2/5 expressing
scrambled shRNA. GFP fluorescence was readily detectable in the
L5 DRG of rats at 4 weeks after the virus injection, and the mRNA
of the α5 subunit was knocked down by 47.6 ± 0.06% (n  5) in
knockdown rats (Figure 5A). Noticeably, there was a small but
significant decrease in basal mechanical sensitivity (increased
withdrawal threshold, see Materials and Methods) in rats
injected with AAV2/5-shRNA-GFP against the α5 subunit
FIGURE 4 | GABA-evoked current from DRG neurons of neuropathic pain rats. (A–C) Comparison of GABA (200 μM)-induced currents from isolated and cultured
L4–6 DRG neurons from sham-operated and CCI-operated rats on the 5th and 14th days after surgery. Left panels are scatter plots of GABA current densities induced by
GABA (200 μM) from small (A), medium (B), and large DRG neurons (C) from different groups of rats, respectively, *p < 0.05 (Mann–Whitney test). Right panels are
representative traces of GABA currents recorded at a holding potential of −60 mV (top) and the comparison of the proportion of GABA-responding and nonresponding
DRG neurons between different groups (bottom) were tested using Pearson’s chi-square test, **p < 0.01. Number of experiments is indicated as n in each panel.
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(10.63 ± 0.93 g, n  16), as compared with the scrambled
shRNA–injected control rats (7.88 ± 0.86 g, n  16;
Figure 5B). But there was no significant difference in basal
thermal sensitivity (withdrawal latency, see Materials and
Methods) between the two groups (Figure 5C).
We then performed CCI on animals that were pre-injected
4 weeks before either with AAV2/5-shRNA-GFP against the α5
subunit or with the AAV2/5 expressing scrambled shRNA. α5
knockdown animals developed milder mechanical and thermal
hyperalgesia than the scrambled shRNA controls (Figures 5D,E).
The alleviation of thermal hyperalgesia was more prominent
(Figure 5E), while mechanical hyperalgesia was only
borderline reduced; only at day 14 after the CCI did the
difference reach significance (Figure 5D). Taken together, the
data presented in Figure 5 suggest that unlike other GABAA
receptor subunits, the α5 subunit plays a pro-algesic role in the
DRG. To further test this, we tried to continuously apply the
specific α5 subunit antagonist L665708 (Quirk et al., 1996;
Delgado-Lezama et al., 2013) to the DRG using an implanted
osmotic minipump (see Materials and Method). The minipumps
were installed at the time of the CCI surgery and slowly released
L665708 (20 μM) at a speed of 0.5 μl/h for approximately 14 days.
As expected, L665708 significantly reduced both mechanical
(Figure 6A) and thermal hyperalgesia (Figure 6B) induced by
CCI surgery. These results suggested that the α5 subunit can be a
therapeutic target for chronic neuropathic pain.
DISCUSSION
In this study, we report the expression of multiple GABAA and
GABAB receptor subunits, as well as GAD67, GAT1-3, and
NKCC1, in the rat DRG. We found that neuropathic injury
induced general downregulation of most GABAA receptor
subunits and GAD67 in the whole DRG tissue and
concomitant reduction in GABA-induced currents in small-
diameter DRG neurons. Uniquely among the GABAA subunits
tested, the α5 subunit was strongly and consistently upregulated.
We also noted that the proportion of GABA-responding
medium-size DRG neurons was also increased following
neuropathic injury. Finally, selective knockdown or blocking of
the α5 GABAA subunit in the DRG in vivo produced moderate
FIGURE 5 | In vivo silencing of the α5 GABAA subunit alleviates neuropathic pain. (A) Injection of AAV2/5-α5 shRNA-GFP into the L5 DRG of rats in vivo produced
strong fluorescence in the DRG and significantly reduced mRNA expression of the α5 subunit in the DRG (n  5), *p < 0.05 (unpaired t test). (B) Injection of AAV2/5-
α5 shRNA-GFP into the L5 DRG of rats significantly increased the mechanical threshold as compared to the baseline threshold and injected scrambled RNA, *p < 0.05
(one-way ANOVA with the LSD post hoc test). (C) No significant change of thermal latency. (D,E) Injection of AAV2/5-α5 shRNA-GFP into the L5 DRG significantly
alleviated mechanical (D) and thermal (E) hyperalgesia produced by CCI. Repeated measures ANOVA with the Bonferroni correction was used for comparison of
hyperalgesia measurements between the groups, #p < 0.05; one-way ANOVA was used for comparison within the corresponding time point: *p < 0.05. Number of
experiments is indicated as n in each panel.
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alleviation of neuropathic hyperalgesia. These findings suggest
that while neuropathic injury is associated with general
weakening of the GABAergic inhibitory system in the DRG,
an elevated α5 GABAA subunit might play an unexpected
excitatory and pro-algesic role in the peripheral sensory system.
GABAA receptors are heteropentameric ligand-gated chloride
channels. Several subunits have been cloned to constitute a
functional GABAA receptor, including α (1–6), β (1–3), c
(1–3), ε, δ, θ, π, and ρ (1–3) (Olsen and Sieghart, 2008). Our
study and earlier reports (Lee et al., 2012; Lee and Gold, 2012; Zhu
et al., 2012; Obradovic et al., 2015; Loeza-Alcocer et al., 2019;
Wilke et al., 2020) demonstrated that DRG neurons express
multiple subunits of the GABAA receptor. It is generally
accepted that GABAA receptors expressed in DRG neurons
would traffic to afferent terminals and would be activated by
GABA released in the spinal cord to produce an inhibitory PAD
(Price et al., 2009; Wilke et al., 2020). Yet, activation of GABAA
receptors in DRG neuron somata could depolarize the membrane
potential and cause action potential failure to propagate through
the t-junction (Du et al., 2017). Thus, normally, depolarization of
either afferent terminals or the somatic/perisomatic
compartment of the afferent fiber would result in an
inhibition of nerve transmission. In this context, weakening of
the peripheral GABAergic system, reported here, is consistent
with a general increase in the peripheral nerve excitability and
peripheral nociceptive transmission associated with chronic pain
development. Our data are also consistent with the widely
acknowledged neuropathic weakening of spinal GABAergic
inhibitory circuits (Braz et al., 2014; Duan et al., 2014;
Mendell, 2014; Peirs et al., 2015; Zhang et al., 2018).
Nevertheless, upregulation of NKCC1, which facilitates the
accumulation of intracellular Cl−, drives excitation of the
membrane potential in afferent terminals and contributes to
injury- or inflammation-induced pain (Zhu et al., 2012). The
NKCC1 function could be upregulated by phosphorylation
(Darman and Forbush, 2002; Flemmer et al., 2002) or
enhancement of its expression and both phenomena were
reported in neuropathic nerves (Hasbargen et al., 2010; Chen
et al., 2014; Modol et al., 2014). We did not examine
phosphorylation of NKCC1 in this study, but we found that
the NKCC1 mRNA level was increased on day 5 post-CCI (there
was no significant change at day 14). This may suggest that
GABAergic inhibition could have been diminished or even
inverted in some DRG neurons which have accumulated
excessive Cl– levels. The proportion of medium-size DRG
neurons responding to GABA was increased on both days 5
and 14 post-CCI. These findings may suggest that a
subpopulation of Aδ DRG neurons, after neuropathic injury
there, could have acquired a de novo sensitivity to GABA. We
further hypothesize that this acquired sensitivity is driven by the
upregulation of the α5 GABAA subunit and that it might be
excitatory. Consistent with this hypothesis, in vivo
downregulation of the α5 subunit produced moderate
alleviation of the CCI-induced hyperalgesia. Future studies are
necessary to put these hypotheses to the test.
Changes in GABAA receptor subunit expression and function
in peripheral nerves under pathologic chronic pain conditions
were indeed demonstrated. For instance, Michael Gold’s group
demonstrated that persistent inflammation increased GABAA
currents in rat DRG neurons through upregulating the high-
affinity GABAA receptor subunits δ and ρ (Lee et al., 2012; Lee
and Gold, 2012). GABAA receptors containing the α5 subunit are
another type of high-affinity GABAA receptor expressed in DRG
neurons of rats (Bravo-Hernandez et al., 2014). Another study
reported that the α5 subunit is mainly present in small-to-
medium–size nonpeptidergic neurons. They provided evidence
that α5 subunit–containing GABAA receptors mediated a tonic
state of excitability of primary afferents in the turtle (Loeza-
Alcocer et al., 2013). Furthermore, a previous study showed that
formalin injection enhanced α5 subunit–containing GABAA
receptor expression in the DRG, and the α5-GABAA receptor
antagonist L655708 prevented and reversed long-lasting
FIGURE 6 | Focal infusion of the α5 GABAA subunit antagonist alleviates neuropathic pain in vivo. Focal DRG application of L655708 (20 μM, ∼0.5 μl/h) using an
osmotic minipump significantly alleviated mechanical (A) and thermal (B) hyperalgesia produced by the CCI. Repeated measures ANOVA with the Bonferroni correction
was used for comparison of hyperalgesia measurements between the groups, #p < 0.05, ##p < 0.01; one-way ANOVA was used for comparison within the
corresponding time point: *p < 0.05. Number of experiments is indicated as n in each panel.
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formalin-induced hypersensitivity (Bravo-Hernandez et al.,
2016). Taken together, our data, together with previous results,
indicate that α5 subunit–containing GABAA receptors indeed
have pronociceptive effects in the periphery.
On the contrary, the α2 subunit of GABAA receptors is
clearly antinociceptive (Obradovic et al., 2015). Thus, crush
injury of the sciatic nerve induced significant downregulation
of the α2 subunit in the rat DRG; selective downregulation of
α2 subunit expression in the DRG significantly worsened
mechanical and thermal hypersensitivity in crush-injured
animals and caused development of significant mechanical
and thermal hypersensitivity in sham animals. Importantly, in
our study, the α2 subunit was found to be significantly
downregulated at day 14 (but not at day 5) post-CCI. The
opposing effect of two similar Cl− channel subunits in sensory
nerves is intriguing and requires further investigation. The
following needs to be taken into consideration: i) these
subunits may be expressed in different subpopulations of
DRG neurons; moreover, α5 subunits may be de novo
expressed in some injured fibers (see above). ii) These
subunits may distribute to different locations in DRG
neurons (i.e., peripheral terminals, somata, stems, dorsal
roots, and central terminals) with potentially diverse local
ECl of the membrane. iii) In contrast to α2, α5 is a high-affinity
GABAA subunit (Farrant and Nusser, 2005; Delgado-Lezama
et al., 2013). iv) There may be other biophysical differences
between neurons expressing α2 and α5 subunits (e.g., the
repertoire and density of voltage-gated Na+ channels),
which may confer a differential impact of Cl− channel
activity on excitability. Thus, opposing effects of channels
belonging to the same family may not be entirely surprising.
Interestingly, the effects of α5 knockdown on thermal and
mechanical sensitivities were different: the basal mechanical
sensitivity was reduced, while the basal heat sensitivity was not
affected (Figures 5C,D). Yet, the knockdown had a much more
prominent effect on thermal hyperalgesia induced by CCI than
on mechanical hyperalgesia (Figures 3D,E). The reasons for such
an effect pattern are yet to be elucidated by further experiments.
In summary, here we report long-lasting plastic changes in the
peripheral GABAergic system induced by neuropathic injury.
Furthermore, we show that the α5 GABAA subunit may have a
unique pro-algesic role and might represent a new therapeutic
target for pain relief.
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